159 related articles for article (PubMed ID: 26817871)
21. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
[TBL] [Abstract][Full Text] [Related]
22. Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study.
Papi G; Corsello SM; Cioni K; Pizzini AM; Corrado S; Carapezzi C; Fadda G; Baldini A; Carani C; Pontecorvi A; Roti E
J Endocrinol Invest; 2006 May; 29(5):427-37. PubMed ID: 16794366
[TBL] [Abstract][Full Text] [Related]
23. Hypercalcitoninemia and thyroid nodules: when cytology (still) matters.
Giovanella L; Giugliano G; Maffini FA; Chiesa F; Bongiovanni M
Diagn Cytopathol; 2014 Nov; 42(11):970-3. PubMed ID: 24550235
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
Karges W; Dralle H; Raue F; Mann K; Reiners C; Grussendorf M; Hüfner M; Niederle B; Brabant G;
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):52-8. PubMed ID: 14758572
[TBL] [Abstract][Full Text] [Related]
25. Influence of chronic autoimmune thyroiditis and papillary thyroid cancer on serum calcitonin levels.
Rosario PW; Calsolari MR
Thyroid; 2013 Jun; 23(6):671-4. PubMed ID: 23327335
[TBL] [Abstract][Full Text] [Related]
26. [Routine serum calcitonin measurement in thyroid nodules].
Storani ME; Bostico ST; Subies FA; Musich M; Oneto A
Medicina (B Aires); 2019; 79(4):271-275. PubMed ID: 31487246
[TBL] [Abstract][Full Text] [Related]
27. Thyroid metastases from typical carcinoid of the lung differentiating between medullary thyroid carcinoma and neuroendocrine tumor metastasis to the thyroid.
La Rosa S; Imperatori A; Giovanella L; Garancini S; Capella C
Thyroid; 2009 May; 19(5):521-6. PubMed ID: 19415998
[TBL] [Abstract][Full Text] [Related]
28. Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence.
Cho YY; Jang HW; Jang JY; Kim TH; Choe JH; Kim JH; Kim JS; Kim SW; Chung JH
Head Neck; 2016 Oct; 38(10):1501-8. PubMed ID: 27062421
[TBL] [Abstract][Full Text] [Related]
29. Calcitonin-Negative Neuroendocrine Tumor of the Thyroid.
Parmer M; Milan S; Torabi A
Int J Surg Pathol; 2017 Apr; 25(2):191-194. PubMed ID: 27658647
[TBL] [Abstract][Full Text] [Related]
30. Indications for surgery and significance of unrecognized cancer in endemic multinodular goiter.
Lasithiotakis K; Grisbolaki E; Koutsomanolis D; Venianaki M; Petrakis I; Vrachassotakis N; Chrysos E; Zoras O; Chalkiadakis G
World J Surg; 2012 Jun; 36(6):1286-92. PubMed ID: 22395348
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of hypercalcitoninemia in patients on maintenance dialysis referred to kidney transplantation.
Akan B; Böhmig G; Sunder-Plassmann G; Borchhardt KA
Clin Nephrol; 2009 May; 71(5):538-42. PubMed ID: 19473614
[TBL] [Abstract][Full Text] [Related]
32. Insulinoma with Hyperprocalcitoninemia and Hypercalcitoninemia Showing Coexpression of Insulin and Calcitonin in Its Tumor Cells.
Kaketaka T; Mineo I; Kimura Y; Ito N; Okauchi Y; Tamura H; Adachi S; Iwahashi H
Intern Med; 2024 May; 63(10):1415-1420. PubMed ID: 37839887
[TBL] [Abstract][Full Text] [Related]
33. Long-term survivor without recurrence after resection of simultaneous solitary pancreatic metastasis from thyroid medullary carcinoma.
Hyodo M; Nagai H; Sata N; Ishitsuka T; Kurihara K; Yoshizawa K; Saitoh K
Hepatogastroenterology; 2003; 50(53):1687-8. PubMed ID: 14571817
[TBL] [Abstract][Full Text] [Related]
34. [How to interprete hypercalcitoninemia?].
Levy-Bohbot N; Patey M; Larbre H; Hecart AC; Caron J; Delemer B
Rev Med Interne; 2006 Aug; 27(8):610-5. PubMed ID: 16857299
[TBL] [Abstract][Full Text] [Related]
35. Benefit of measuring basal serum calcitonin to detect medullary thyroid carcinoma in a Danish population with a high prevalence of thyroid nodules.
Hasselgren M; Hegedüs L; Godballe C; Bonnema SJ
Head Neck; 2010 May; 32(5):612-8. PubMed ID: 19691107
[TBL] [Abstract][Full Text] [Related]
36. Histopathological and molecular studies in patients with goiter and hypercalcitoninemia: reactive or neoplastic C-cell hyperplasia?
Verga U; Ferrero S; Vicentini L; Brambilla T; Cirello V; Muzza M; Beck-Peccoz P; Fugazzola L
Endocr Relat Cancer; 2007 Jun; 14(2):393-403. PubMed ID: 17639053
[TBL] [Abstract][Full Text] [Related]
37. Differentiation between thyroidal and ectopic calcitonin secretion in patients with coincidental thyroid nodules and pancreatic tumors - a report of two cases.
Schneider R; Heverhagen AE; Moll R; Bartsch DK; Schlosser K
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):520-3. PubMed ID: 19691012
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of Serum Calcitonin in Patients Without a Suspicious History of Medullary Thyroid Carcinoma and with Thyroid Nodules Without an Indication for Fine-Needle Aspiration or with Benign Cytology.
Rosario PW; Calsolari MR
Horm Metab Res; 2016 Jun; 48(6):372-276. PubMed ID: 27203410
[TBL] [Abstract][Full Text] [Related]
39. Metastatic medullary thyroid carcinoma or calcitonin-secreting carcinoid tumor of lung? A diagnostic dilemma in a patient with lung mass and thyroid nodule.
Vahidi S; Stewart J; Amin K; Racila E; Li F
Diagn Cytopathol; 2018 Apr; 46(4):345-348. PubMed ID: 29124912
[TBL] [Abstract][Full Text] [Related]
40. Calcitonin: current concepts and differential diagnosis.
Kiriakopoulos A; Giannakis P; Menenakos E
Ther Adv Endocrinol Metab; 2022; 13():20420188221099344. PubMed ID: 35614985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
